GRK-03

N/A

Report date: 2024/01/18 17:34:48
NME

Base Information

Drug NameGRK-03
Drug Alias NameGRK-03GRK-008
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsBrain Injuries, Traumatic
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaPhase 1 Clinical
Originator CompaniesHuiankai (Xiamen) Pharmaceutical Technology Co LtdQuanzhou Haichuang Medical Technology Co LtdSuzhou Gelanke Medical Technology Co Ltd
China Registration ClassClass 1 Chemical Drug in China

Develop Information

Active CompaniesQuanzhou Haichuang Medical Technology Co LtdHuiankai (Xiamen) Pharmaceutical Technology Co LtdSuzhou Gelanke Medical Technology Co Ltd
Inactive CompaniesN/A
Active IndicationsBrain Injuries, Traumatic
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A